StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMMay 29, 2026, 04:15 PM

Equillium Stockholders Approve Reverse Stock Split, Increase Authorized Shares

AI Summary

Equillium, Inc. held its 2026 Annual Meeting of Stockholders, where key proposals were approved. Stockholders voted to approve an amendment to the company's certificate of incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-20, at the Board's discretion. Additionally, the authorized number of common stock shares was increased from 200,000,000 to 400,000,000. Charles McDermott and Bruce Steel were elected as Class II directors, and the Board size was reduced to six members. The appointment of Crowe LLP as the independent registered public accounting firm for 2026 was also ratified.

Key Highlights

  • Stockholders approved a reverse stock split at a ratio of 1-for-2 to 1-for-20, at the Board's discretion.
  • Stockholders approved increasing the authorized common stock from 200,000,000 to 400,000,000 shares.
  • Charles McDermott and Bruce Steel were elected as Class II directors until the 2029 Annual Meeting.
  • The Board of Directors size was reduced from seven to six members following Peter Colabuono's departure.
  • Crowe LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
  • 54,287,329 shares (85.86%) were present or represented by proxy at the Annual Meeting.